Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

doi:10.1084/jem.173.3.647

This Article

	Full Text (PDF, 1169K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Barth, R. J.
	Articles by Rosenberg, S. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Barth, R. J., Jr
	Articles by Rosenberg, S. A.


Social Bookmarking

	What's this?

ARTICLES

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

RJ Barth Jr, JJ Mule, PJ Spiess and SA Rosenberg
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

We have investigated the mechanisms whereby adoptively transferred murine CD8+ lymphocytes mediate tumor regressions. Noncytolytic, CD8+ tumor-infiltrating lymphocytes (TIL) eradicated established lung tumors in irradiated mice. Many cytolytic and noncytolytic CD8+ TIL cultures specifically secreted interferon gamma (IFN-gamma) and tumor necrosis factor when stimulated with tumor cells in vitro. The effectiveness of TIL when adoptively transferred to mice bearing micrometastases correlated better with their ability to specifically secrete lymphokines than with their cytotoxicity in vitro. In 14 of 15 tests, therapeutically effective TIL specifically secreted IFN-gamma in vitro, whereas only 1 of 11 ineffective TIL specifically secreted IFN-gamma. In contrast, only 8 of 15 therapeutically effective TIL were cytolytic. Antibodies to TNF inhibited the effectiveness of two adoptively transferred TIL cultures. In five experiments, antibodies to IFN-gamma abrogated the ability of four different CD8+ TIL cultures to mediate tumor regressions, indicating that secretion of IFN-gamma is an essential part of the mechanism of action of TIL.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Levy, M. Y., Sidana, A., Chowdhury, W. H., Solomon, S. B., Drake, C. G., Rodriguez, R., Fuchs, E. J. (2009). Cyclophosphamide Unmasks an Antimetastatic Effect of Local Tumor Cryoablation. J. Pharmacol. Exp. Ther. 330: 596-601 [Abstract] [Full Text]
Tatum, A. M., Mylin, L. M., Bender, S. J., Fischer, M. A., Vigliotti, B. A., Tevethia, M. J., Tevethia, S. S., Schell, T. D. (2008). CD8+ T Cells Targeting a Single Immunodominant Epitope are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors. J. Immunol. 181: 4406-4417 [Abstract] [Full Text]
Janicki, C. N., Jenkinson, S. R., Williams, N. A., Morgan, D. J. (2008). Loss of CTL Function among High-Avidity Tumor-Specific CD8+ T Cells following Tumor Infiltration. Cancer Res. 68: 2993-3000 [Abstract] [Full Text]
Li, Z., Pradera, F., Kammertoens, T., Li, B., Liu, S., Qin, Z. (2007). Cross-Talk between T Cells and Innate Immune Cells Is Crucial for IFN-{gamma}-Dependent Tumor Rejection. J. Immunol. 179: 1568-1576 [Abstract] [Full Text]
Dace, D. S., Chen, P. W., Niederkorn, J. Y. (2007). CD8+ T Cells Circumvent Immune Privilege in the Eye and Mediate Intraocular Tumor Rejection by a TNF-{alpha}-Dependent Mechanism. J. Immunol. 178: 6115-6122 [Abstract] [Full Text]
Liu, S., Foster, B. A., Chen, T., Zheng, G., Chen, A. (2007). Modifying Dendritic Cells via Protein Transfer for Antitumor Therapeutics. Clin. Cancer Res. 13: 283-291 [Abstract] [Full Text]
Hu, J., Yuan, X., Belladonna, M. L., Ong, J. M., Wachsmann-Hogiu, S., Farkas, D. L., Black, K. L., Yu, J. S. (2006). Induction of Potent Antitumor Immunity by Intratumoral Injection of Interleukin 23-Transduced Dendritic Cells.. Cancer Res. 66: 8887-8896 [Abstract] [Full Text]
Saji, H., Song, W., Furumoto, K., Kato, H., Engleman, E. G. (2006). Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy. Clin. Cancer Res. 12: 2568-2574 [Abstract] [Full Text]
Li, Q., Carr, A. L., Donald, E. J., Skitzki, J. J., Okuyama, R., Stoolman, L. M., Chang, A. E. (2005). Synergistic Effects of IL-12 and IL-18 in Skewing Tumor-Reactive T-Cell Responses Towards a Type 1 Pattern. Cancer Res. 65: 1063-1070 [Abstract] [Full Text]
Nagata, H., Arai, T., Soejima, Y., Suzuki, H., Ishii, H., Hibi, T. (2004). Limited Capability of Regional Lymph Nodes to Eradicate Metastatic Cancer Cells. Cancer Res. 64: 8239-8248 [Abstract] [Full Text]
Teitz-Tennenbaum, S., Li, Q., Rynkiewicz, S., Ito, F., Davis, M. A., Mcginn, C. J., Chang, A. E. (2003). Radiotherapy Potentiates the Therapeutic Efficacy of Intratumoral Dendritic Cell Administration. Cancer Res. 63: 8466-8475 [Abstract] [Full Text]
Bedrosian, I., Mick, R., Xu, S., Nisenbaum, H., Faries, M., Zhang, P., Cohen, P. A., Koski, G., Czerniecki, B. J. (2003). Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+ T-Cell Function in Melanoma Patients. JCO 21: 3826-3835 [Abstract] [Full Text]
Rubio, M.-T., Kim, Y.-M., Sachs, T., Mapara, M., Zhao, G., Sykes, M. (2003). Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-{gamma}. Blood 102: 2300-2307 [Abstract] [Full Text]
Qin, Z., Schwartzkopff, J., Pradera, F., Kammertoens, T., Seliger, B., Pircher, H., Blankenstein, T. (2003). A Critical Requirement of Interferon {gamma}-mediated Angiostasis for Tumor Rejection by CD8+ T Cells. Cancer Res. 63: 4095-4100 [Abstract] [Full Text]
Ullenhag, G. J., Frodin, J.-E., Mosolits, S., Kiaii, S., Hassan, M., Bonnet, M. C., Moingeon, P., Mellstedt, H., Rabbani, H. (2003). Immunization of Colorectal Carcinoma Patients with a Recombinant Canarypox Virus Expressing the Tumor Antigen Ep-CAM/KSA (ALVAC-KSA) and Granulocyte Macrophage Colony- stimulating Factor Induced a Tumor-specific Cellular Immune Response. Clin. Cancer Res. 9: 2447-2456 [Abstract] [Full Text]
Schuler, T., Blankenstein, T. (2003). Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells. J. Immunol. 170: 4427-4431 [Abstract] [Full Text]
Poehlein, C. H., Hu, H.-M., Yamada, J., Assmann, I., Alvord, W. G., Urba, W. J., Fox, B. A. (2003). TNF Plays an Essential Role in Tumor Regression after Adoptive Transfer of Perforin/IFN-{gamma} Double Knockout Effector T Cells. J. Immunol. 170: 2004-2013 [Abstract] [Full Text]
Rubinstein, M. P., Kadima, A. N., Salem, M. L., Nguyen, C. L., Gillanders, W. E., Nishimura, M. I., Cole, D. J. (2003). Transfer of TCR Genes into Mature T Cells Is Accompanied by the Maintenance of Parental T Cell Avidity. J. Immunol. 170: 1209-1217 [Abstract] [Full Text]
Hess, S. D., Egilmez, N. K., Bailey, N., Anderson, T. M., Mathiowitz, E., Bernstein, S. H., Bankert, R. B. (2003). Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-{gamma}. J. Immunol. 170: 400-412 [Abstract] [Full Text]
Feng, Y., Wang, D., Yuan, R., Parker, C. M., Farber, D. L., Hadley, G. A. (2002). CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8+ T Cells. JEM 196: 877-886 [Abstract] [Full Text]
Qin, Z., Harders, C., Cao, X., Huber, C., Blankenstein, T., Seliger, B. (2002). Increased Tumorigenicity, but Unchanged Immunogenicity, of Transporter for Antigen Presentation 1-deficient Tumors. Cancer Res. 62: 2856-2860 [Abstract] [Full Text]
Chang, A. E., Redman, B. G., Whitfield, J. R., Nickoloff, B. J., Braun, T. M., Lee, P. P., Geiger, J. D., Mule, J. J. (2002). A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer. Clin. Cancer Res. 8: 1021-1032 [Abstract] [Full Text]
Seki, N., Brooks, A. D., Carter, C. R. D., Back, T. C., Parsoneault, E. M., Smyth, M. J., Wiltrout, R. H., Sayers, T. J. (2002). Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin. J. Immunol. 168: 3484-3492 [Abstract] [Full Text]
Le, H. N., Lee, N. C., Tsung, K., Norton, J. A. (2001). Pre-Existing Tumor-Sensitized T Cells Are Essential for Eradication of Established Tumors by IL-12 and Cyclophosphamide Plus IL-12. J. Immunol. 167: 6765-6772 [Abstract] [Full Text]
Geiger, J. D., Hutchinson, R. J., Hohenkirk, L. F., McKenna, E. A., Yanik, G. A., Levine, J. E., Chang, A. E., Braun, T. M., Mule, J. J. (2001). Vaccination Of Pediatric Solid Tumor Patients with Tumor Lysate-pulsed Dendritic Cells Can Expand Specific T Cells and Mediate Tumor Regression. Cancer Res. 61: 8513-8519 [Abstract] [Full Text]
Kirk, C. J., Hartigan-O'Connor, D., Mule, J. J. (2001). The Dynamics of the T-Cell Antitumor Response: Chemokine-secreting Dendritic Cells Can Prime Tumor-reactive T Cells Extranodally. Cancer Res. 61: 8794-8802 [Abstract] [Full Text]
Kemp, R. A., Ronchese, F. (2001). Tumor-Specific Tc1, But Not Tc2, Cells Deliver Protective Antitumor Immunity. J. Immunol. 167: 6497-6502 [Abstract] [Full Text]
Bonnotte, B., Larmonier, N., Favre, N., Fromentin, A., Moutet, M., Martin, M., Gurbuxani, S., Solary, E., Chauffert, B., Martin, F. (2001). Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System. J. Immunol. 167: 5077-5083 [Abstract] [Full Text]
Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen, H. Q., Engels, F. H. C., Cohen, P. A., Czerniecki, B. J. (2001). Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development. Blood 98: 2489-2497 [Abstract] [Full Text]
Tanigawa, K., Takeshita, N., Craig, R. A., Phillips, K., Knibbs, R. N., Chang, A. E., Stoolman, L. M. (2001). Tumor-Specific Responses in Lymph Nodes Draining Murine Sarcomas Are Concentrated in Cells Expressing P-Selectin Binding Sites. J. Immunol. 167: 3089-3098 [Abstract] [Full Text]
Winter, H., Hu, H.-M., McClain, K., Urba, W. J., Fox, B. A. (2001). Immunotherapy of Melanoma: A Dichotomy in the Requirement for IFN-{{gamma}} in Vaccine-Induced Antitumor Immunity Versus Adoptive Immunotherapy. J. Immunol. 166: 7370-7380 [Abstract] [Full Text]
Shimizu, K., Thomas, E. K., Giedlin, M., Mulé, J. J. (2001). Enhancement of Tumor Lysate- and Peptide-pulsed Dendritic Cell-based Vaccines by the Addition of Foreign Helper Protein. Cancer Res. 61: 2618-2624 [Abstract] [Full Text]
Candido, K. A., Shimizu, K., McLaughlin, J. C., Kunkel, R., Fuller, J. A., Redman, B. G., Thomas, E. K., Nickoloff, B. J., Mulé, J. J. (2001). Local Administration of Dendritic Cells Inhibits Established Breast Tumor Growth: Implications for Apoptosis-inducing Agents. Cancer Res. 61: 228-236 [Abstract] [Full Text]
Lambert, L. A., Gibson, G. R., Maloney, M., Durell, B., Noelle, R. J., Barth, R. J. Jr. (2001). Intranodal Immunization with Tumor Lysate-pulsed Dendritic Cells Enhances Protective Antitumor Immunity. Cancer Res. 61: 641-646 [Abstract] [Full Text]
Peng, L., Krauss, J. C., Plautz, G. E., Mukai, S., Shu, S., Cohen, P. A. (2000). T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-{gamma} Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics. J. Immunol. 165: 7116-7124 [Abstract] [Full Text]
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., Cannon, M. J. (2000). Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol. 74: 4729-4737 [Abstract] [Full Text]
Karanikas, V., Lodding, J., Maino, V. C., McKenzie, I. F. C. (2000). Flow Cytometric Measurement of Intracellular Cytokines Detects Immune Responses in MUC1 Immunotherapy. Clin. Cancer Res. 6: 829-837 [Abstract] [Full Text]
Dobrzanski, M. J., Reome, J. B., Dutton, R. W. (2000). Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor. J. Immunol. 164: 916-925 [Abstract] [Full Text]
Bronte, V., Apolloni, E., Ronca, R., Zamboni, P., Overwijk, W. W., Surman, D. R., Restifo, N. P., Zanovello, P. (2000). Genetic Vaccination with "Self" Tyrosinase-related Protein 2 Causes Melanoma Eradication but not Vitiligo. Cancer Res. 60: 253-258 [Abstract] [Full Text]
Winter, H., Hu, H.-M., Urba, W. J., Fox, B. A. (1999). Tumor Regression After Adoptive Transfer of Effector T Cells Is Independent of Perforin or Fas Ligand (APO-1L/CD95L). J. Immunol. 163: 4462-4472 [Abstract] [Full Text]
Dobrzanski, M. J., Reome, J. B., Dutton, R. W. (1999). Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T Cell Subpopulations in Established Pulmonary Metastases. J. Immunol. 162: 6671-6680 [Abstract] [Full Text]
Motte, R. N. L., Sharpe, A. H., Bluestone, J. A., Mokyr, M. B. (1999). Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism. J. Immunol. 162: 4817-4823 [Abstract] [Full Text]
Shimizu, K., Fields, R. C., Giedlin, M., Mule, J. J. (1999). Systemic administration of interleukin 2�enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc. Natl. Acad. Sci. USA 96: 2268-2273 [Abstract] [Full Text]
Zeh, H. J. III, Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., Yang, J. C. (1999). High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy. J. Immunol. 162: 989-994 [Abstract] [Full Text]
Wu, P. C., Alexander, H. R., Huang, J., Hwu, P., Gnant, M., Berger, A. C., Turner, E., Wilson, O., Libutti, S. K. (1999). In Vivo Sensitivity of Human Melanoma to Tumor Necrosis Factor (TNF)-{{alpha}} Is Determined by Tumor Production of the Novel Cytokine Endothelial-Monocyte Activating Polypeptide II (EMAPII). Cancer Res. 59: 205-212 [Abstract] [Full Text]
Hu, H.-M., Urba, W. J., Fox, B. A. (1998). Gene-Modified Tumor Vaccine with Therapeutic Potential Shifts Tumor-Specific T Cell Response from a Type 2 to a Type 1 Cytokine Profile. J. Immunol. 161: 3033-3041 [Abstract] [Full Text]
Mackey, M. F., Gunn, J. R., Maliszewski, C., Kikutani, H., Noelle, R. J., Barth, R. J. Jr. (1998). Cutting Edge: Dendritic Cells Require Maturation via CD40 to Generate Protective Antitumor Immunity. J. Immunol. 161: 2094-2098 [Abstract] [Full Text]
Prevost-Blondel, A., Zimmermann, C., Stemmer, C., Kulmburg, P., Rosenthal, F. M., Pircher, H. (1998). Tumor-Infiltrating Lymphocytes Exhibiting High Ex Vivo Cytolytic Activity Fail to Prevent Murine Melanoma Tumor Growth In Vivo. J. Immunol. 161: 2187-2194 [Abstract] [Full Text]
Fields, R. C., Shimizu, K., Mule, J. J. (1998). Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487 [Abstract] [Full Text]
Zilocchi, C., Stoppacciaro, A., Chiodoni, C., Parenza, M., Terrazzini, N., Colombo, M. P. (1998). Interferon {gamma}-independent Rejection of Interleukin 12-transduced Carcinoma Cells Requires CD4+ T Cells and Granulocyte/Macrophage Colony-stimulating Factor. JEM 188: 133-143 [Abstract] [Full Text]
Ostankovitch, M., Guichard, G., Connan, F., Muller, S., Chaboissier, A., Hoebeke, J., Choppin, J., Briand, J.-P., Guillet, J.-G. (1998). A Partially Modified Retro-Inverso Pseudopeptide Modulates the Cytokine Profile of CTL Specific for an Influenza Virus Epitope. J. Immunol. 161: 200-208 [Abstract] [Full Text]
Kagamu, H., Shu, S. (1998). Purification of L-Selectinlow Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T Lymphocytes. J. Immunol. 160: 3444-3452 [Abstract] [Full Text]
Nagoshi, M., Goedegebuure, P. S., Burger, U. L., Sadanaga, N., Chang, M. P., Eberlein, T. J. (1998). Successful Adoptive Cellular Immunotherapy Is Dependent on Induction of a Host Immune Response Triggered by Cytokine (IFN-{gamma} and Granulocyte/Macrophage Colony-Stimulating Factor) Producing Donor Tumor-Infiltrating Lymphocytes. J. Immunol. 160: 334-344 [Abstract] [Full Text]
Maria, B. L., Medina, C. D., Hoang, K. B.N., Phillips, M. I. (1997). Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 1. The Bench. J Child Neurol 12: 1-12 [Abstract]
Chang, A. E., Geiger, J. D., Sondak, V. K, Shu, S. (1993). Adoptive Cellular Therapy of Malignancy. Arch Surg 128: 1281-1290 [Abstract]
Schmeichel, C. J., Loeb, J. M. (1992). Human Gene Therapy: A Role for the Primary Care Physician. Arch Fam Med 1: 113-120 [Abstract]